• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

Global HIV Therapeutics Market Size, Status and Forecast 2020-2026

report cover
  • 31 July 2020
  • Pharmaceuticals
  • 99 Pages
  • Report Code: 24LS-16407
  • Formate :   
Download FREE Report Sample Download PDF File

HIV Therapeutics -MARKET ADVISORY SERVICES

HIV Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global HIV Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Boehringer Ingelheim International GmbH
Merck & Co.
ViiV Healthcare
AbbVie
F. Hoffmann-La Roche Ltd.
Teva Pharmaceutical Industries Ltd.
Bristol-Myers Squibb
Gilead Sciences
Johnson & Johnson
Cipla Limited

Market segment by Type, the product can be split into
Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Entry and Fusion Inhibitors
Protease Inhibitors (PIs)
Integrase Inhibitors
Coreceptor Antagonists
Market segment by Application, split into
Hospitals
Clinics
Labs

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by HIV Therapeutics Revenue
1.4 Market by Type
1.4.1 Global HIV Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
1.4.3 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
1.4.4 Entry and Fusion Inhibitors
1.4.5 Protease Inhibitors (PIs)
1.4.6 Integrase Inhibitors
1.4.7 Coreceptor Antagonists
1.5 Market by Application
1.5.1 Global HIV Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Labs
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global HIV Therapeutics Market Perspective (2015-2026)
2.2 Global HIV Therapeutics Growth Trends by Regions
2.2.1 HIV Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 HIV Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 HIV Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 HIV Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key HIV Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top HIV Therapeutics Players by Market Size
3.1.1 Global Top HIV Therapeutics Players by Revenue (2015-2020)
3.1.2 Global HIV Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global HIV Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global HIV Therapeutics Market Concentration Ratio
3.2.1 Global HIV Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by HIV Therapeutics Revenue in 2019
3.3 HIV Therapeutics Key Players Head office and Area Served
3.4 Key Players HIV Therapeutics Product Solution and Service
3.5 Date of Enter into HIV Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global HIV Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global HIV Therapeutics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global HIV Therapeutics Market Size by Application (2015-2020)
5.2 Global HIV Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America HIV Therapeutics Market Size (2015-2020)
6.2 HIV Therapeutics Key Players in North America (2019-2020)
6.3 North America HIV Therapeutics Market Size by Type (2015-2020)
6.4 North America HIV Therapeutics Market Size by Application (2015-2020)

7 Europe
7.1 Europe HIV Therapeutics Market Size (2015-2020)
7.2 HIV Therapeutics Key Players in Europe (2019-2020)
7.3 Europe HIV Therapeutics Market Size by Type (2015-2020)
7.4 Europe HIV Therapeutics Market Size by Application (2015-2020)

8 China
8.1 China HIV Therapeutics Market Size (2015-2020)
8.2 HIV Therapeutics Key Players in China (2019-2020)
8.3 China HIV Therapeutics Market Size by Type (2015-2020)
8.4 China HIV Therapeutics Market Size by Application (2015-2020)

9 Japan
9.1 Japan HIV Therapeutics Market Size (2015-2020)
9.2 HIV Therapeutics Key Players in Japan (2019-2020)
9.3 Japan HIV Therapeutics Market Size by Type (2015-2020)
9.4 Japan HIV Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia HIV Therapeutics Market Size (2015-2020)
10.2 HIV Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia HIV Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia HIV Therapeutics Market Size by Application (2015-2020)

11 India
11.1 India HIV Therapeutics Market Size (2015-2020)
11.2 HIV Therapeutics Key Players in India (2019-2020)
11.3 India HIV Therapeutics Market Size by Type (2015-2020)
11.4 India HIV Therapeutics Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America HIV Therapeutics Market Size (2015-2020)
12.2 HIV Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America HIV Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America HIV Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Boehringer Ingelheim International GmbH
13.1.1 Boehringer Ingelheim International GmbH Company Details
13.1.2 Boehringer Ingelheim International GmbH Business Overview
13.1.3 Boehringer Ingelheim International GmbH HIV Therapeutics Introduction
13.1.4 Boehringer Ingelheim International GmbH Revenue in HIV Therapeutics Business (2015-2020))
13.1.5 Boehringer Ingelheim International GmbH Recent Development
13.2 Merck & Co.
13.2.1 Merck & Co. Company Details
13.2.2 Merck & Co. Business Overview
13.2.3 Merck & Co. HIV Therapeutics Introduction
13.2.4 Merck & Co. Revenue in HIV Therapeutics Business (2015-2020)
13.2.5 Merck & Co. Recent Development
13.3 ViiV Healthcare
13.3.1 ViiV Healthcare Company Details
13.3.2 ViiV Healthcare Business Overview
13.3.3 ViiV Healthcare HIV Therapeutics Introduction
13.3.4 ViiV Healthcare Revenue in HIV Therapeutics Business (2015-2020)
13.3.5 ViiV Healthcare Recent Development
13.4 AbbVie
13.4.1 AbbVie Company Details
13.4.2 AbbVie Business Overview
13.4.3 AbbVie HIV Therapeutics Introduction
13.4.4 AbbVie Revenue in HIV Therapeutics Business (2015-2020)
13.4.5 AbbVie Recent Development
13.5 F. Hoffmann-La Roche Ltd.
13.5.1 F. Hoffmann-La Roche Ltd. Company Details
13.5.2 F. Hoffmann-La Roche Ltd. Business Overview
13.5.3 F. Hoffmann-La Roche Ltd. HIV Therapeutics Introduction
13.5.4 F. Hoffmann-La Roche Ltd. Revenue in HIV Therapeutics Business (2015-2020)
13.5.5 F. Hoffmann-La Roche Ltd. Recent Development
13.6 Teva Pharmaceutical Industries Ltd.
13.6.1 Teva Pharmaceutical Industries Ltd. Company Details
13.6.2 Teva Pharmaceutical Industries Ltd. Business Overview
13.6.3 Teva Pharmaceutical Industries Ltd. HIV Therapeutics Introduction
13.6.4 Teva Pharmaceutical Industries Ltd. Revenue in HIV Therapeutics Business (2015-2020)
13.6.5 Teva Pharmaceutical Industries Ltd. Recent Development
13.7 Bristol-Myers Squibb
13.7.1 Bristol-Myers Squibb Company Details
13.7.2 Bristol-Myers Squibb Business Overview
13.7.3 Bristol-Myers Squibb HIV Therapeutics Introduction
13.7.4 Bristol-Myers Squibb Revenue in HIV Therapeutics Business (2015-2020)
13.7.5 Bristol-Myers Squibb Recent Development
13.8 Gilead Sciences
13.8.1 Gilead Sciences Company Details
13.8.2 Gilead Sciences Business Overview
13.8.3 Gilead Sciences HIV Therapeutics Introduction
13.8.4 Gilead Sciences Revenue in HIV Therapeutics Business (2015-2020)
13.8.5 Gilead Sciences Recent Development
13.9 Johnson & Johnson
13.9.1 Johnson & Johnson Company Details
13.9.2 Johnson & Johnson Business Overview
13.9.3 Johnson & Johnson HIV Therapeutics Introduction
13.9.4 Johnson & Johnson Revenue in HIV Therapeutics Business (2015-2020)
13.9.5 Johnson & Johnson Recent Development
13.10 Cipla Limited
13.10.1 Cipla Limited Company Details
13.10.2 Cipla Limited Business Overview
13.10.3 Cipla Limited HIV Therapeutics Introduction
13.10.4 Cipla Limited Revenue in HIV Therapeutics Business (2015-2020)
13.10.5 Cipla Limited Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables

Table 1. HIV Therapeutics Key Market Segments

Table 2. Key Players Covered: Ranking by HIV Therapeutics Revenue

Table 3. Ranking of Global Top HIV Therapeutics Manufacturers by Revenue (US$ Million) in 2019

Table 4. Global HIV Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026

Table 5. Key Players of Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)

Table 6. Key Players of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

Table 7. Key Players of Entry and Fusion Inhibitors

Table 8. Key Players of Protease Inhibitors (PIs)

Table 9. Key Players of Integrase Inhibitors

Table 10. Key Players of Coreceptor Antagonists

Table 11. Global HIV Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026

Table 12. Global HIV Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026

Table 13. Global HIV Therapeutics Market Size by Regions (2015-2020) (US$ Million)

Table 14. Global HIV Therapeutics Market Share by Regions (2015-2020)

Table 15. Global HIV Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)

Table 16. Global HIV Therapeutics Market Share by Regions (2021-2026)

Table 17. Market Top Trends

Table 18. Key Drivers: Impact Analysis

Table 19. Key Challenges

Table 20. HIV Therapeutics Market Growth Strategy

Table 21. Main Points Interviewed from Key HIV Therapeutics Players

Table 22. Global HIV Therapeutics Revenue by Players (2015-2020) (Million US$)

Table 23. Global HIV Therapeutics Market Share by Players (2015-2020)

Table 24. Global Top HIV Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HIV Therapeutics as of 2019)

Table 25. Global HIV Therapeutics by Players Market Concentration Ratio (CR5 and HHI)

Table 26. Key Players Headquarters and Area Served

Table 27. Key Players HIV Therapeutics Product Solution and Service

Table 28. Date of Enter into HIV Therapeutics Market

Table 29. Mergers & Acquisitions, Expansion Plans

Table 30. Global HIV Therapeutics Market Size by Type (2015-2020) (Million US$)

Table 31. Global HIV Therapeutics Market Size Share by Type (2015-2020)

Table 32. Global HIV Therapeutics Revenue Market Share by Type (2021-2026)

Table 33. Global HIV Therapeutics Market Size Share by Application (2015-2020)

Table 34. Global HIV Therapeutics Market Size by Application (2015-2020) (Million US$)

Table 35. Global HIV Therapeutics Market Size Share by Application (2021-2026)

Table 36. North America Key Players HIV Therapeutics Revenue (2019-2020) (Million US$)

Table 37. North America Key Players HIV Therapeutics Market Share (2019-2020)

Table 38. North America HIV Therapeutics Market Size by Type (2015-2020) (Million US$)

Table 39. North America HIV Therapeutics Market Share by Type (2015-2020)

Table 40. North America HIV Therapeutics Market Size by Application (2015-2020) (Million US$)

Table 41. North America HIV Therapeutics Market Share by Application (2015-2020)

Table 42. Europe Key Players HIV Therapeutics Revenue (2019-2020) (Million US$)

Table 43. Europe Key Players HIV Therapeutics Market Share (2019-2020)

Table 44. Europe HIV Therapeutics Market Size by Type (2015-2020) (Million US$)

Table 45. Europe HIV Therapeutics Market Share by Type (2015-2020)

Table 46. Europe HIV Therapeutics Market Size by Application (2015-2020) (Million US$)

Table 47. Europe HIV Therapeutics Market Share by Application (2015-2020)

Table 48. China Key Players HIV Therapeutics Revenue (2019-2020) (Million US$)

Table 49. China Key Players HIV Therapeutics Market Share (2019-2020)

Table 50. China HIV Therapeutics Market Size by Type (2015-2020) (Million US$)

Table 51. China HIV Therapeutics Market Share by Type (2015-2020)

Table 52. China HIV Therapeutics Market Size by Application (2015-2020) (Million US$)

Table 53. China HIV Therapeutics Market Share by Application (2015-2020)

Table 54. Japan Key Players HIV Therapeutics Revenue (2019-2020) (Million US$)

Table 55. Japan Key Players HIV Therapeutics Market Share (2019-2020)

Table 56. Japan HIV Therapeutics Market Size by Type (2015-2020) (Million US$)

Table 57. Japan HIV Therapeutics Market Share by Type (2015-2020)

Table 58. Japan HIV Therapeutics Market Size by Application (2015-2020) (Million US$)

Table 59. Japan HIV Therapeutics Market Share by Application (2015-2020)

Table 60. Southeast Asia Key Players HIV Therapeutics Revenue (2019-2020) (Million US$)

Table 61. Southeast Asia Key Players HIV Therapeutics Market Share (2019-2020)

Table 62. Southeast Asia HIV Therapeutics Market Size by Type (2015-2020) (Million US$)

Table 63. Southeast Asia HIV Therapeutics Market Share by Type (2015-2020)

Table 64. Southeast Asia HIV Therapeutics Market Size by Application (2015-2020) (Million US$)

Table 65. Southeast Asia HIV Therapeutics Market Share by Application (2015-2020)

Table 66. India Key Players HIV Therapeutics Revenue (2019-2020) (Million US$)

Table 67. India Key Players HIV Therapeutics Market Share (2019-2020)

Table 68. India HIV Therapeutics Market Size by Type (2015-2020) (Million US$)

Table 69. India HIV Therapeutics Market Share by Type (2015-2020)

Table 70. India HIV Therapeutics Market Size by Application (2015-2020) (Million US$)

Table 71. India HIV Therapeutics Market Share by Application (2015-2020)

Table 72. Central & South America Key Players HIV Therapeutics Revenue (2019-2020) (Million US$)

Table 73. Central & South America Key Players HIV Therapeutics Market Share (2019-2020)

Table 74. Central & South America HIV Therapeutics Market Size by Type (2015-2020) (Million US$)

Table 75. Central & South America HIV Therapeutics Market Share by Type (2015-2020)

Table 76. Central & South America HIV Therapeutics Market Size by Application (2015-2020) (Million US$)

Table 77. Central & South America HIV Therapeutics Market Share by Application (2015-2020)

Table 78. Boehringer Ingelheim International GmbH Company Details

Table 79. Boehringer Ingelheim International GmbH Business Overview

Table 80. Boehringer Ingelheim International GmbH Product

Table 81. Boehringer Ingelheim International GmbH Revenue in HIV Therapeutics Business (2015-2020) (Million US$)

Table 82. Boehringer Ingelheim International GmbH Recent Development

Table 83. Merck & Co. Company Details

Table 84. Merck & Co. Business Overview

Table 85. Merck & Co. Product

Table 86. Merck & Co. Revenue in HIV Therapeutics Business (2015-2020) (Million US$)

Table 87. Merck & Co. Recent Development

Table 88. ViiV Healthcare Company Details

Table 89. ViiV Healthcare Business Overview

Table 90. ViiV Healthcare Product

Table 91. ViiV Healthcare Revenue in HIV Therapeutics Business (2015-2020) (Million US$)

Table 92. ViiV Healthcare Recent Development

Table 93. AbbVie Company Details

Table 94. AbbVie Business Overview

Table 95. AbbVie Product

Table 96. AbbVie Revenue in HIV Therapeutics Business (2015-2020) (Million US$)

Table 97. AbbVie Recent Development

Table 98. F. Hoffmann-La Roche Ltd. Company Details

Table 99. F. Hoffmann-La Roche Ltd. Business Overview

Table 100. F. Hoffmann-La Roche Ltd. Product

Table 101. F. Hoffmann-La Roche Ltd. Revenue in HIV Therapeutics Business (2015-2020) (Million US$)

Table 102. F. Hoffmann-La Roche Ltd. Recent Development

Table 103. Teva Pharmaceutical Industries Ltd. Company Details

Table 104. Teva Pharmaceutical Industries Ltd. Business Overview

Table 105. Teva Pharmaceutical Industries Ltd. Product

Table 106. Teva Pharmaceutical Industries Ltd. Revenue in HIV Therapeutics Business (2015-2020) (Million US$)

Table 107. Teva Pharmaceutical Industries Ltd. Recent Development

Table 108. Bristol-Myers Squibb Company Details

Table 109. Bristol-Myers Squibb Business Overview

Table 110. Bristol-Myers Squibb Product

Table 111. Bristol-Myers Squibb Revenue in HIV Therapeutics Business (2015-2020) (Million US$)

Table 112. Bristol-Myers Squibb Recent Development

Table 113. Gilead Sciences Business Overview

Table 114. Gilead Sciences Product

Table 115. Gilead Sciences Company Details

Table 116. Gilead Sciences Revenue in HIV Therapeutics Business (2015-2020) (Million US$)

Table 117. Gilead Sciences Recent Development

Table 118. Johnson & Johnson Company Details

Table 119. Johnson & Johnson Business Overview

Table 120. Johnson & Johnson Product

Table 121. Johnson & Johnson Revenue in HIV Therapeutics Business (2015-2020) (Million US$)

Table 122. Johnson & Johnson Recent Development

Table 123. Cipla Limited Company Details

Table 124. Cipla Limited Business Overview

Table 125. Cipla Limited Product

Table 126. Cipla Limited Revenue in HIV Therapeutics Business (2015-2020) (Million US$)

Table 127. Cipla Limited Recent Development

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

List of Figures

Figure 1. Global HIV Therapeutics Market Share by Type: 2020 VS 2026

Figure 2. Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs) Features

Figure 3. Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Features

Figure 4. Entry and Fusion Inhibitors Features

Figure 5. Protease Inhibitors (PIs) Features

Figure 6. Integrase Inhibitors Features

Figure 7. Coreceptor Antagonists Features

Figure 8. Global HIV Therapeutics Market Share by Application: 2020 VS 2026

Figure 9. Hospitals Case Studies

Figure 10. Clinics Case Studies

Figure 11. Labs Case Studies

Figure 12. HIV Therapeutics Report Years Considered

Figure 13. Global HIV Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)

Figure 14. Global HIV Therapeutics Market Share by Regions: 2020 VS 2026

Figure 15. Global HIV Therapeutics Market Share by Regions (2021-2026)

Figure 16. Porter's Five Forces Analysis

Figure 17. Global HIV Therapeutics Market Share by Players in 2019

Figure 18. Global Top HIV Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HIV Therapeutics as of 2019

Figure 19. The Top 10 and 5 Players Market Share by HIV Therapeutics Revenue in 2019

Figure 20. North America HIV Therapeutics Market Size YoY Growth (2015-2020) (Million US$)

Figure 21. Europe HIV Therapeutics Market Size YoY Growth (2015-2020) (Million US$)

Figure 22. China HIV Therapeutics Market Size YoY Growth (2015-2020) (Million US$)

Figure 23. Japan HIV Therapeutics Market Size YoY Growth (2015-2020) (Million US$)

Figure 24. Southeast Asia HIV Therapeutics Market Size YoY Growth (2015-2020) (Million US$)

Figure 25. India HIV Therapeutics Market Size YoY Growth (2015-2020) (Million US$)

Figure 26. Central & South America HIV Therapeutics Market Size YoY Growth (2015-2020) (Million US$)

Figure 27. Bottom-up and Top-down Approaches for This Report

Figure 28. Data Triangulation

Figure 29. Key Executives Interviewed

Boehringer Ingelheim International GmbH

Merck & Co.

ViiV Healthcare

AbbVie

F. Hoffmann-La Roche Ltd.

Teva Pharmaceutical Industries Ltd.

Bristol-Myers Squibb

Gilead Sciences

Johnson & Johnson

Cipla Limited

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $3237

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase